Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.050 GeneticVariation disease BEFREE Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers. 9328150 1997
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.040 AlteredExpression disease BEFREE Serum levels of carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA) are not elevated in most patients with extramammary Paget disease (EMPD) without metastasis. 30706452 2019
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.040 Biomarker disease BEFREE Serum carcinoembryonic antigen (CEA) and cytokeratin 19 fragment 21-1 (CYFRA 21-1) levels have been identified as candidate biomarkers for tumour progression in EMPD. 30791097 2019
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.040 Biomarker disease BEFREE Concentrations of serum CYFRA 21-1 and carcinoembryonic antigen (CEA) in 13 cases of EMPD were measured prior to undergoing treatment at Sapporo Medical University Hospital from January 2014 to May 2016. 28150330 2017
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.040 AlteredExpression disease BEFREE Although PSSCIS and EMPD share CK7 and CK19 expression, PSSCIS is consistently mucin and carcinoembryonic antigen negative. 18156986 2008
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.030 Biomarker disease BEFREE Implementation of cytokeratin 7 immunostain has increased the ability to detect extramammary Paget disease on frozen section. 31084720 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.030 AlteredExpression disease BEFREE Among the 60 sweat gland, 18 sebaceous and 5 trichoblastic carcinomas, 11% expressed PD-L1 in ≥ 1% tumor cells, more frequently sweat gland carcinomas (13%, 8/60) including apocrine carcinoma (40%, 2/5) and invasive extramammary Paget disease (57%, 4/7). 30953116 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.030 AlteredExpression disease BEFREE However, PD-L1 expression by EMPD tumor cells did not correlate with the density of CD3-, CD8-, or PD-1-positive cells in the tumor-associated immune infiltrate or other clinicopathologic parameters. 31146499 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.030 AlteredExpression disease BEFREE Expression of CD3, PD-L1 and CTLA-4 in mammary and extra-mammary Paget disease. 29943071 2018
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.030 Biomarker disease BEFREE To evaluate the local recurrence rate of Mohs micrographic surgery (MMS) supplemented with intraoperative immunohistochemistry for cytokeratin-7 (MMS + CK-7) for primary and recurrent EMPD. 29517496 2018
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.030 Biomarker disease BEFREE Pathological examination of biopsies from the erythema suggested secondary extramammary Paget disease with positive cytokeratin-7 and -20 expressions and negative GCDFP-15 expression. 30458812 2018
Entrez Id: 367
Gene Symbol: AR
AR
0.030 AlteredExpression disease BEFREE Our current results indicate that MPD and EMPD presented different expression pattern of AR and ER and would help to further identify the molecular subtype of MPD and EMPD for adjuvant hormonal therapy, especially for patients with penoscrotal EMPD. 29082243 2017
Entrez Id: 367
Gene Symbol: AR
AR
0.030 Biomarker disease BEFREE Results suggest that AR may play a role in EMPD tumorigenesis. 16086738 2005
Entrez Id: 367
Gene Symbol: AR
AR
0.030 AlteredExpression disease BEFREE Immunohistochemistry revealed that 24 of 30 (80%) cases of EMPD variably expressed nuclear androgen receptor. 11005214 2000
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.020 Biomarker disease BEFREE We also observed that intraepithelial EMPD had predominantly cytoplasmic p16 immunoreactivity, whereas nuclear p16 immunoreactivity was mainly seen in invasive EMPD components. 31033795 2020
Entrez Id: 5304
Gene Symbol: PIP
PIP
0.020 Biomarker disease BEFREE PSA was positive in 1 patient who had a history of prostate cancer, whereas other prostate markers (NKX3.1 and prostein) were negative, and CK7 and GCDFP15 were positive, rendering primary EMPD diagnosis. 31290785 2019
Entrez Id: 4360
Gene Symbol: MRC1
MRC1
0.020 PosttranslationalModification disease BEFREE This study aims to confirm the methylation and expression of MMR genes in EMPD. 30784122 2019
Entrez Id: 5304
Gene Symbol: PIP
PIP
0.020 AlteredExpression disease BEFREE Pathological examination of biopsies from the erythema suggested secondary extramammary Paget disease with positive cytokeratin-7 and -20 expressions and negative GCDFP-15 expression. 30458812 2018
Entrez Id: 2625
Gene Symbol: GATA3
GATA3
0.020 Biomarker disease BEFREE GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15. 28693610 2017
Entrez Id: 2625
Gene Symbol: GATA3
GATA3
0.020 Biomarker disease BEFREE GATA3 was positive in all extramammary Paget disease cases tested (13 cases), and it has no value for differentiating between primary and secondary vulvar Paget disease from the urological tract. 27633145 2017
Entrez Id: 4360
Gene Symbol: MRC1
MRC1
0.020 GeneticVariation disease BEFREE Genetic tests and functional analysis of mismatch repair (MMR) genes were performed in EMPD. 27487738 2016
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.020 PosttranslationalModification disease BEFREE Furthermore, PIK3CA and AKT1 mutations were significantly correlated with CDH1 hypermethylation which could explain why the majority of EMPD cases with mutant PIK3CA and AKT1 were invasive. 22821211 2013
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.020 Biomarker disease BEFREE Our study demonstrates that genetic variants associated with constitutive activation of RAS/RAF and PI3K/AKT pathways are involved in the pathogenesis of EMPD. 22821211 2013
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.020 GeneticVariation disease BEFREE Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease. 22522847 2012
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.020 Biomarker disease BEFREE The Wnt-1/β-catenin pathway may not play an important role in the progression of extramammary Paget's disease. 21352264 2011